Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis.
Oliveira-da-Silva JA, Lage DP, Ramos FF, Machado AS, Tavares GSV, Mendonça DVC, Pereira IAG, Martins VT, Carvalho LM, Ludolf F, Santos TTO, Reis TAR, Oliveira CS, Bandeira RS, Silva AM, Costa LE, Oliveira JS, Duarte MC, Menezes-Souza D, Roatt BM, Teixeira AL, Coelho EAF. Oliveira-da-Silva JA, et al. Among authors: mendonca dvc. Mol Immunol. 2020 Aug;124:161-171. doi: 10.1016/j.molimm.2020.06.010. Epub 2020 Jun 22. Mol Immunol. 2020. PMID: 32585510
Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasis.
Dias DS, Martins VT, Ribeiro PAF, Ramos FF, Lage DP, Tavares GSV, Mendonça DVC, Chávez-Fumagalli MA, Oliveira JS, Silva ES, Gomes DA, Rodrigues MA, Duarte MC, Galdino AS, Menezes-Souza D, Coelho EAF. Dias DS, et al. Among authors: mendonca dvc. Parasitology. 2018 May;145(6):740-751. doi: 10.1017/S0031182017001731. Epub 2017 Nov 8. Parasitology. 2018. PMID: 29113597
Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans.
Ribeiro PAF, Dias DS, Lage DP, Costa LE, Martins VT, Tavares GSV, Mendonça DVC, Lima MP, Oliveira JS, Steiner BT, Machado-de-Ávila RA, Roatt BM, Chávez-Fumagalli MA, Menezes-Souza D, Duarte MC, Teixeira AL, Coelho EAF. Ribeiro PAF, et al. Among authors: mendonca dvc. Cell Immunol. 2018 Sep;331:67-77. doi: 10.1016/j.cellimm.2018.05.009. Epub 2018 May 29. Cell Immunol. 2018. PMID: 29871740
A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis.
Ribeiro PAF, Dias DS, Novais MVM, Lage DP, Tavares GSV, Mendonça DVC, Oliveira JS, Chávez-Fumagalli MA, Roatt BM, Duarte MC, Menezes-Souza D, Ludolf F, Tavares CAP, Oliveira MC, Coelho EAF. Ribeiro PAF, et al. Among authors: mendonca dvc. Cytokine. 2018 Nov;111:131-139. doi: 10.1016/j.cyto.2018.08.019. Epub 2018 Aug 22. Cytokine. 2018. PMID: 30142534
A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection.
Tavares GSV, Mendonça DVC, Miyazaki CK, Lage DP, Soyer TG, Carvalho LM, Ottoni FM, Dias DS, Ribeiro PAF, Antinarelli LMR, Ludolf F, Duarte MC, Coimbra ES, Chávez-Fumagalli MA, Roatt BM, Menezes-Souza D, Barichello JM, Alves RJ, Coelho EAF. Tavares GSV, et al. Among authors: mendonca dvc. Parasitol Int. 2019 Feb;68(1):63-72. doi: 10.1016/j.parint.2018.10.005. Epub 2018 Oct 16. Parasitol Int. 2019. PMID: 30339837
In silico Leishmania proteome mining applied to identify drug target potential to be used to treat against visceral and tegumentary leishmaniasis.
Chávez-Fumagalli MA, Lage DP, Tavares GSV, Mendonça DVC, Dias DS, Ribeiro PAF, Ludolf F, Costa LE, Coelho VTS, Coelho EAF. Chávez-Fumagalli MA, et al. Among authors: mendonca dvc. J Mol Graph Model. 2019 Mar;87:89-97. doi: 10.1016/j.jmgm.2018.11.014. Epub 2018 Nov 29. J Mol Graph Model. 2019. PMID: 30522092
Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection.
Ribeiro PAF, Dias DS, Lage DP, Martins VT, Costa LE, Santos TTO, Ramos FF, Tavares GSV, Mendonça DVC, Ludolf F, Gomes DA, Rodrigues MA, Chávez-Fumagalli MA, Silva ES, Galdino AS, Duarte MC, Roatt BM, Menezes-Souza D, Teixeira AL, Coelho EAF. Ribeiro PAF, et al. Among authors: mendonca dvc. Mol Immunol. 2019 Feb;106:108-118. doi: 10.1016/j.molimm.2018.12.025. Epub 2018 Dec 27. Mol Immunol. 2019. PMID: 30594673
Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG, Mendonça DVC, Tavares GSV, Lage DP, Dias DS, Ribeiro PAF, Perin L, Ludolf F, Coelho VTS, Ferreira ACG, Neves PHAS, Matos GF, Chávez-Fumagalli MA, Coimbra ES, Pereira GR, Coelho EAF, Antinarelli LMR. Soyer TG, et al. Among authors: mendonca dvc. Exp Parasitol. 2019 Apr;199:30-37. doi: 10.1016/j.exppara.2019.02.019. Epub 2019 Feb 25. Exp Parasitol. 2019. PMID: 30817917
A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis.
Sousa JKT, Antinarelli LMR, Mendonça DVC, Lage DP, Tavares GSV, Dias DS, Ribeiro PAF, Ludolf F, Coelho VTS, Oliveira-da-Silva JA, Perin L, Oliveira BA, Alvarenga DF, Chávez-Fumagalli MA, Brandão GC, Nobre V, Pereira GR, Coimbra ES, Coelho EAF. Sousa JKT, et al. Among authors: mendonca dvc. Parasitol Int. 2019 Dec;73:101966. doi: 10.1016/j.parint.2019.101966. Epub 2019 Jul 27. Parasitol Int. 2019. PMID: 31362122
37 results